These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7826070)

  • 1. [Treatment of recurrent uterine endometrial cancer in adjuvant therapy with medroxyprogesterone acetate (MPA) in addition of etoposide].
    Ishizaki T; Yamamoto T; Itoh R; Yasuda J; Fujita H; Okada H
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):137-40. PubMed ID: 7826070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of recurrent endometrial cancer successfully treated with oral administration of etoposide].
    Tsuruchi N; Jimi S
    Gan To Kagaku Ryoho; 1992 Jan; 19(1):103-5. PubMed ID: 1729957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hormonal therapy for endometrial adenocarcinoma].
    Susumu N; Aoki D; Suzuki N; Nozawa S
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):934-45. PubMed ID: 11478142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of oral etoposide in recurrent or refractory endometrial adenocarcinoma: a southwest oncology group study.
    Poplin EA; Liu PY; Delmore JE; Wilczynski S; Moore DF; Potkul RK; Fine BA; Hannigan EV; Alberts DS
    Gynecol Oncol; 1999 Sep; 74(3):432-5. PubMed ID: 10479505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II trial of prolonged oral etoposide (VP-16) as second-line therapy for advanced and recurrent endometrial carcinoma: a Gynecologic Oncology Group study.
    Rose PG; Blessing JA; Lewandowski GS; Creasman WT; Webster KD
    Gynecol Oncol; 1996 Oct; 63(1):101-4. PubMed ID: 8898177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of recurrent uterine cervical cancer successfully treated with etoposide].
    Kobayashi H; Kawashima Y
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3279-82. PubMed ID: 2782919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of doxorubicin, 5-fluorouracil, etoposide, and cisplatin in advanced or recurrent endometrial carcinoma.
    Pierga JY; Diéras V; Beuzeboc P; Dorval T; Palangié T; Jouve M; Scholl SM; Garcia-Giralt E; Pouillart P
    Gynecol Oncol; 1997 Aug; 66(2):246-9. PubMed ID: 9264570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of recurrent ovarian cancer successfully treated with etoposide].
    Wakisaka T; Sou S
    Gan To Kagaku Ryoho; 1988 May; 15(5):1795-8. PubMed ID: 3369875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Estimation of medroxyprogesterone acetate (MPA) and etoposide against a human uterine endometrial cancer].
    Ishizaki T; Yamamoto T; Itoh R; Yasuda J; Fujita H; Okada H
    Gan To Kagaku Ryoho; 1994 Oct; 21(14):2521-3. PubMed ID: 7944503
    [No Abstract]   [Full Text] [Related]  

  • 10. [CDDP-resistant early recurrent uterine cervical cancer successfully treated with low-dose oral etoposide: a case report].
    Beppu M; Hiura M; Nogawa T; Kawakami Y; Yokoyama T; Chiba T
    Gan To Kagaku Ryoho; 1998 May; 25(6):933-6. PubMed ID: 9617335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy in metastatic or recurrent endometrial carcinoma].
    Deppe G; Baumann P; Munkarah A
    Zentralbl Gynakol; 2000; 122(7):355-60. PubMed ID: 10951705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of advanced or recurrent endometrial carcinoma with combination of etoposide, cisplatin, and 5-fluorouracil: a phase II study.
    Pierga JY; Dieras V; Paraiso D; Dorval T; Palangie T; Beuzeboc P; Jouve M; Scholl SM; Garcia-Giralt E; Pouillart P
    Gynecol Oncol; 1996 Jan; 60(1):59-63. PubMed ID: 8557229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Rose PG; Blessing JA; Van Le L; Waggoner S
    Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of stage III ovarian carcinoma successfully treated with oral etoposide].
    Takeda S; Takada S; Kojima T; Kinoshita K; Sakamoto S
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1929-31. PubMed ID: 2393311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology.
    Ross AH; Boyd ME; Colgan TJ; Ferenczy A; Fugere P; Lorrain J
    Obstet Gynecol; 1993 Nov; 82(5):773-9. PubMed ID: 8414325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of fertility-preserving treatment in young women with endometrial carcinomas.
    Niwa K; Tagami K; Lian Z; Onogi K; Mori H; Tamaya T
    BJOG; 2005 Mar; 112(3):317-20. PubMed ID: 15713146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily low-dose oral etoposide for recurrent epithelial ovarian cancer after platinum-based therapy.
    Moosavi AS; Gilani MM; Tehranian A; Esfahani JK
    J Obstet Gynaecol; 2004 Apr; 24(3):292-3. PubMed ID: 15203631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on CAF + medroxyprogesterone acetate (MPA) therapy for advanced or recurrent breast cancer--comparison between MPA 600 mg and 1,200 mg. Kyushu CAFT Therapy Study Group (Third Study)].
    Mitsuyama S; Ohno S; Koga T; Takayama T; Yamashita J; Ogawa M; Shirouzu K; Sugimachi K; Nomura Y; Ogawa N
    Gan To Kagaku Ryoho; 1999 Nov; 26(13):2029-36. PubMed ID: 10584567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination with medroxyprogesterone acetate and chemotherapy making possible complete removal of uterine corpus carcinoma].
    Tajima H; Okada T; Fujimori Y; Tomioka Y; Hirano M; Yoshida T; Ikeda S; Hata T
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2461-4. PubMed ID: 2526620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Two cases of endometrial stromal sarcoma (ESS) in which survival was prolonged by administration of MPA].
    Ishibashi M; Nakayama K; Shamima Y; Katagiri A; Iida K; Nakayama N; Miyazaki K
    Gan To Kagaku Ryoho; 2008 May; 35(5):857-61. PubMed ID: 18487930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.